| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 34.132 | 41.185 | 76.668 |
| Total Income - EUR | - | - | - | - | - | - | - | 34.132 | 41.185 | 76.703 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 11.266 | 31.854 | 34.799 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 22.865 | 9.330 | 41.904 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 22.531 | 8.927 | 40.628 |
| Employees | - | - | - | - | - | - | - | 2 | 2 | 2 |
Check the financial reports for the company - Mar Lex Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | - | 23.715 | 16.321 | 45.294 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 18.381 | 1.021 | 24.229 |
| Cash | - | - | - | - | - | - | - | 5.334 | 15.300 | 21.065 |
| Shareholders Funds | - | - | - | - | - | - | - | 22.531 | 14.812 | 40.636 |
| Social Capital | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | - | 1.184 | 1.509 | 4.658 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Mar Lex Lab S.r.l.